GGrantIndex
Sort

39,280 grants matching leukemia

Understanding mechanisms of BTK inhibitor and degrader resistance in patients with chronic lymphocytic leukemia

$351,131
Justin Taylor · University Of Miami School Of Medicine · R01 · FY2024 · CA

Enhancing TET activity for the treatment of hematological malignancy

$351,131
Luisa Cimmino · University Of Miami School Of Medicine · R01 · FY2025 · CA

Understanding mechanisms of BTK inhibitor and degrader resistance in patients with chronic lymphocytic leukemia

$351,131
Justin Taylor · University Of Miami School Of Medicine · R01 · FY2025 · CA

Enhancing TET activity for the treatment of hematological malignancy

$351,131
Luisa Cimmino · University Of Miami School Of Medicine · R01 · FY2023 · CA

Genes, cells, and pathways that regulate urochordate allogeneic stem cell competition and their mammalian homologues

$351,121
Irving Lerner Weissman · Stanford University · R01 · FY2017 · GM

Arginine deiminase as an Anti-Cancer Therapy

$351,083
Phoenix Pharmacologics, Inc. · R44 · FY2002 · CA

Transcriptional regulation of TAL1/SCL in normal and malignant hematopoiesis

$351,079
Suming Huang · University Of Florida · R01 · FY2012 · HL

Effects of Polymorphism on Levels of KIR Expression

$351,067
Peter R Parham · University Of California, San Francisco · P01 · FY2007 · AI

Project 1: Role of HTLV-1 Hbz in Transformation and Disease

$351,024
Patrick Lee Green · Ohio State University · P01 · FY2018 · CA

VITAMIN D--CHEMICAL AND RELATED STUDIES

$351,011
University Of California Riverside · R01 · FY2000 · DK

A PDGFR inhibitor for the treatment of pulmonary arterial hypertension

$351,008
Lawrence S. Zisman · Pulmokine, Inc. · R43 · FY2010 · HL

Role of the Hypoxia-Inducible Factor-1alpha in Myelodysplastic Syndromes

$351,000
Gang Huang · Cincinnati Childrens Hosp Med Ctr · R01 · FY2018 · DK

Role of the Hypoxia-Inducible Factor-1alpha in Myelodysplastic Syndromes

$351,000
Gang Huang · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · DK

Role of the Hypoxia-Inducible Factor-1alpha in Myelodysplastic Syndromes

$351,000
Gang Huang · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · DK

Role of the Hypoxia-Inducible Factor-1alpha in Myelodysplastic Syndromes

$351,000
Gang Huang · Cincinnati Childrens Hosp Med Ctr · R01 · FY2015 · DK

Role of the Hypoxia-Inducible Factor-1alpha in Myelodysplastic Syndromes

$351,000
Gang Huang · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · DK

Polyglutamine Toxicity in Drosophila

$351,000
State University Of New York At Buffalo · R01 · FY2002 · NS

Nutritional Cell Cycle and Differentiation Control

$350,987
Andrew Yen · Cornell University · R01 · FY2013 · CA

Function of MLL in transcription regulation

$350,854
Yali Dou · University Of Southern California · R01 · FY2021 · GM

Function of MLL in transcription regulation

$350,854
Yali Dou · University Of Southern California · R01 · FY2022 · GM

Function of MLL in transcription regulation

$350,854
Yali Dou · University Of Southern California · R01 · FY2020 · GM

Function of MLL in transcription regulation

$350,854
Yali Dou · University Of Southern California · R01 · FY2023 · GM

Engineered CD4 Tregs Targeting B-ALL and AML

$350,849
John E Wagner · University Of Minnesota · P01 · FY2023 · CA

Role of p21 activated kinase in Leukemogenesis

$350,846
Reuben Kapur · Indiana University Indianapolis · R01 · FY2024 · CA

Genes, cells, and pathways that regulate urochordate allogeneic stem cell competition and their mammalian homologues

$350,835
Irving Lerner Weissman · Stanford University · R01 · FY2016 · GM